kidney disease Archives - Journal for Clinical Studies

Current Edition

Regional News

CSL to buy Vifor for $11.7B in biopharma’s largest M&A deal this year

In a move to diversify its business, Australian biopharma CSL has agreed to acquire Vifor Pharma for $11.7 billion. The deal would give CSL—heavily dependent on vacci...

15 December 2021 Regional News a CSL Behring | Fresenius

Continue Reading →

news

Proteomics and Dimerix partner to improve the treatment of kidney disease

Australia-based Proteomics International (PI) has developed PromarkerD, a predictive and diagnostic test for diabetic kidney disease that measures a protein biomarker...

20 December 2017 news biomarker | blood

Continue Reading →

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Rare Disease Ebook

Decentralised Clinical Trials in The EU

RWS – eBook

It’s All About Stem Cells

Covid-19

Current Edition

CSL to buy Vifor for $11.7B in biopharma’s largest M&A deal this year

Proteomics and Dimerix partner to improve the treatment of kidney disease

Journal for Clinical Studies